Work

Dalotuzumab, a recombinant humanized mAb targeted against IGFR1 for the treatment of cancer.

Year: 2010

Type: article

Source: PubMed

Authors: Mario Scartozzi, Maristella Bianconi, Elena Maccaroni, Riccardo Giampieri, Rossana Berardi, Stefano Cascinu

Institutions: Marche Polytechnic University, Azienda Ospedaliero-Universitaria delle Marche

Language: English

Topic: Growth Hormone and Insulin-like Growth Factors

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2401973235

FWCI: 4.491

Cites:

Cited by: 60

Related to: 10